HDL acceptor capacities for cholesterol efflux from macrophages and lipid transfer are both acutely reduced after myocardial infarction
- 20 December 2017
- journal article
- research article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 478, 51-56
- https://doi.org/10.1016/j.cca.2017.12.031
Abstract
No abstract availableKeywords
Funding Information
- State of São Paulo Research Support Foundation (14/03742-0)
This publication has 36 references indexed in Scilit:
- High-Density Lipoproteins and the Immune SystemJournal of Lipids, 2013
- Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery diseaseJCI Insight, 2011
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and AtherosclerosisThe New England Journal of Medicine, 2011
- The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Rebound inflammatory response during the acute phase of myocardial infarction after simvastatin withdrawalAtherosclerosis, 2009
- Inflammation Impairs Reverse Cholesterol Transport In VivoCirculation, 2009
- Molecular regulation of HDL metabolism and function: implications for novel therapiesJCI Insight, 2006
- Determination of human plasma phospholipid transfer protein mass and activityMethods, 2005
- High-Density Lipoproteins Protect Isolated Rat Hearts From Ischemia-Reperfusion Injury by Reducing Cardiac Tumor Necrosis Factor-α Content and Enhancing Prostaglandin ReleaseCirculation Research, 2003
- Plasma phospholipid mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parametersBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996